Changfa Qu
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Acylation modification mediated post-translational modifications learning signature reveals ZDHHC18 promotes progression of lung adenocarcinoma by attenuating immunocyte activation.
Journal: Frontiers in immunology
Published: February 03, 2026
The relationship between blood biomarkers and prognosis of pathologic stage IA pure-solid non-small cell lung cancer patients.
Journal: Journal of thoracic disease
Published: December 02, 2024
Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients.
Journal: Journal of cardiothoracic surgery
Published: January 10, 2024
Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer.
Journal: Frontiers in genetics
Published: June 29, 2023
Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: December 05, 2022
Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis.
Journal: Frontiers in pharmacology
Published: October 27, 2022
Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: July 07, 2017
MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.
Journal: Clinical laboratory
Published: May 25, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026